August 1, 2013
When author Jessica Wapner visited Portland for a recent reading of her new book, it’s no surprise that she asked OHSU Knight Cancer Institute Director Brian Druker to join her on stage. It was his story that served as the happy ending to The Philadelphia Chromosome: A Mutant Gene and the Quest to Cure Cancer at the Genetic Level.
The talk covered highlights from Wapner’s book, which chronicles more than a half century of discoveries that eventually led to a new approach to treating cancer. Druker’s career and the research he did that led to Gleevec figures prominently.
This article was written by Elisa Williams. It first appeared on the Knight News blog